Figure 3.

Inhibition of uroplakin III (UPIII) expression in CBA/J/Hsd mouse bladders following treatment withas-APF. Bladder sections from mice treated with as-APF following bladder epithelial injury show decreased UPIII immunofluorescence staining as compared to mice treated with PBS or inactive control nonglycosylated peptide. A) 7 days of as-APF treatment; B) 21 days of as-APF treatment. Representative data shown for the 3 mice in each treatment group from one experiment; experiment performed three times. (200X final magnification).

Keay et al. BMC Urology 2012 12:17   doi:10.1186/1471-2490-12-17
Download authors' original image